Related Experiment Video
Updated: May 6, 2026

In Vitro Assessment of Cardiac Function Using Skinned Cardiomyocytes
Published on: June 22, 2020
Skeletal muscle involvement in cardiomyopathies
Giuseppe Limongelli1, Raffaella D'Alessandro, Valeria Maddaloni
1aMonaldi Hospital, Second University of Naples, Naples, Italy bInstitute of Cardiovascular Science, University College London and The Heart Hospital, University College London Hospitals Trust, London cInstitute of Genetic Medicine, Newcastle University, International Centre for Life, Newcastle upon Tyne, UK.
Heart and skeletal muscle disorders share features, with muscle weakness often preceding heart issues. Early cardiac screening is vital for diagnosing neuromuscular conditions and preventing heart complications.
Area of Science:
- Cardiology
- Neurology
- Genetics
Background:
- Primary cardiomyopathies and primary neuromuscular disorders share molecular, anatomical, and clinical features.
- Skeletal muscle weakness can indicate various underlying conditions, including neuromuscular, mitochondrial, storage, or metabolic disorders.
- Cardiac involvement in neuromuscular disorders may manifest subtly, with heart failure or arrhythmias as the first sign.
Purpose of the Study:
- To highlight the interconnectedness of heart and skeletal muscle disorders.
- To emphasize the importance of early cardiac screening in patients with neuromuscular conditions.
- To guide proactive diagnosis and family evaluation for at-risk individuals.
Main Methods:
- Review of clinical features linking cardiomyopathies and neuromuscular disorders.
- Discussion of diagnostic indicators for skeletal muscle weakness.
- Emphasis on cardiovascular evaluation methods like ECG and echocardiogram.
Main Results:
- Skeletal muscle weakness often precedes cardiomyopathy but can be subtle.
- Early cardiac manifestations include heart failure, conduction defects, and arrhythmias.
- Proactive screening aids in identifying individuals at risk for cardiac events.
Conclusions:
- Cardiologists should actively screen for neuromuscular disorders to enable early diagnosis and family evaluation.
- Identifying at-risk individuals allows for prophylactic treatments such as pacemakers or anticoagulation.
- Integrated care is crucial for managing patients with combined cardiac and skeletal muscle disorders.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Structure of Cardiac Muscles
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
Myocarditis I: Introduction
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy

